← Back to All Filings

Zimmer Biomet Director Michael J. Farrell Acquires Phantom Stock Units

Low SignificanceOctober 2, 2026 at 5:24:21 PM EDT

ZIMMER BIOMET HOLDINGS, INC.

$ZBH4CIK: 0001136869

Subscribe to track ZBH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# SEC Form 4 Alert: Zimmer Biomet Holdings, Inc. ($ZBH)

**Insider:** Michael J. Farrell
**Role:** Director
**Transaction Date:** September 30, 2026
**Filing Date:** October 02, 2026

### Transaction Summary
* **Security:** Phantom Stock Units
* **Action:** Acquisition (Deferred Compensation Accrual)
* **Shares:** +417.363 units
* **Price / Valuation:** $89.85 per unit (Nominal: $0.00)
* **Gross Value:** ~$37,500.07
* **Post-Transaction Holdings:** 20,073.731 units

**Trading Significance:** Low (Routine quarterly deferred compensation accrual)

Comprehensive Analysis

Executive Summary

On October 2, 2026, Zimmer Biomet Holdings, Inc. ($ZBH) filed a Form 4 on behalf of Director Michael J. Farrell. The filing reports an acquisition of 417.363 phantom stock units on September 30, 2026, accrued under the company's Deferred Compensation Plan for Non-Employee Directors at an underlying valuation of $89.85 per unit, representing approximately $37,500 in quarterly retainer deferrals.

Transaction Details

  • Security: Phantom Stock Units (convertible 1-for-1 into cash post-service)
  • Transaction Code: 'A' (Grant, award, or other acquisition under an SEC Rule 16b-3 plan)
  • Units Acquired: 417.363
  • Effective Conversion Price: $89.85
  • Implied Retainer Amount: $37,500.07
  • Post-Transaction Total: 20,073.731 phantom stock units held directly (including 49.652 units from dividend reinvestment on July 31, 2026)

Market & Trading Impact

This filing represents standard quarterly director compensation deferred into cash-settled phantom equity rather than an open-market transaction. Because it reflects routine non-employee director board compensation and contains no active discretionary market buying or selling, it carries low trading significance for ZBH shares.

Topics:#ZBH#ZimmerBiomet#SECForm4#InsiderTrading#BoardOfDirectors

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.